Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
about
Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised peoplePolymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised peopleMeta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile NeutropeniaSystematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeA hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, AsAdvancing the Field: Evidence for New Management Strategies in Invasive Fungal InfectionsHematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how.Enhancing molecular approaches for diagnosis of fungal infections.Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014.Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-Primary gastrointestinal aspergillosis 6 months after allogeneic hematopoietic cell transplantation: a case report.Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.Assessing responses to treatment of opportunistic mycoses and salvage strategies.
P2860
Q24186283-9E36E322-542E-4700-BF89-DE16025A5139Q24186897-BF4D4EB7-DA38-426D-91CE-A0A372AB4910Q26778187-A151DE5B-BA00-4D54-88D4-090D6498D49CQ28083874-3A5498F5-C530-43DE-87C9-E826945FB845Q34532546-1EA48A48-3C51-44AA-BF1D-72E4C6132447Q35672258-C393BA12-19A4-4B8A-ABDC-7BCF64BC2B1CQ37287794-C518384E-677A-4690-9C89-E138A59815F2Q38049498-D13428C8-672D-4FBD-B11C-4AC5BB213DC5Q38082740-58181910-B735-4745-84B2-AD7CD8ACE8C8Q38130168-0287DCCD-1479-46F0-A684-6C35A100D5B2Q38165198-00AFF62F-93BE-4A24-B330-290536AE2110Q38211509-0C821BEF-A4F9-48D0-B270-9FB737B63857Q38284458-297F8C51-117B-4402-B0A8-2460B0B38D09Q39195902-9F2B744F-9296-4C37-ADBA-7F6DCC43184EQ39264020-F5E11B9F-EE00-47EF-B246-22A8B86BB462Q41929754-691AC02D-2114-4032-AA02-3AB20FA19B73Q42267015-3529D5CA-C48A-4415-B75E-F8619F4DB96DQ47416112-8CCB2DB5-F70D-43A9-9EFF-0C7C02C8469FQ54346621-ACDCF4A2-59BE-4B62-9226-1516348DC3E8
P2860
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@en
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@nl
type
label
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@en
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@nl
prefLabel
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@en
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@nl
P2093
P2860
P356
P1476
Randomized PCR-based therapy a ...... tioning and hematopoietic SCT.
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2010.38
P407
P577
2010-03-01T00:00:00Z
P5875
P6179
1050011141